Logo-hpp
2024: Two-year Impact Factor: 2.8
Scopus Journal Metrics
CiteScore (2024):6.1
 
Platinum
Open Access

Health Promot Perspect. 2022;12(3): 282-285.
doi: 10.34172/hpp.2022.36
PMID: 36686053
PMCID: PMC9808913
Scopus ID: 85148951415
  Abstract View: 1531
  PDF Download: 932
  Full Text View: 744

Perspective

Strengthening Africa’s capacity for vaccine research: Needs and challenges

Adedoyin John-Joy Owolade 1* ORCID logo, Taiwo Oluwaseun Sokunbi 1, Favour Oluwatobi Aremu 1, Esther Oluwatosin Omotosho 2, Blessing Abai Sunday 3, Yusuff Adebayo Adebisi 2, Aniekan Ekpenyong 4, Abdulhammed Opeyemi Babatunde 5

1 Faculty of Pharmacy, Obafemi Awolowo University, Ile Ife, Nigeria
2 Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
3 Faculty of Pharmacy, University of Uyo, Uyo, Nigeria
4 Global Health Policy Unit, University of Edinburgh, Scotland, United Kingdom
5 Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria
*Corresponding Author: Corresponding Author: Adedoyin John-Joy Owolade, Email: , Email: doywolad@gmail.com

Abstract

Vaccine development and production harbinger the control and eradication of infectious diseases. Vaccination played a huge role in the curtailment of disease outbreaks like smallpox and polio, especially in Africa. Despite the high demand for several vaccines in Africa due to the highly infectious disease burden, the continent still lacks adequate capacity for vaccine research and development. This paper aims to discuss the need and challenges of Africa to strengthen its capacity for vaccine research and development and also highlight practical recommendations. Some of the needs for Africa to prioritize vaccine research and development include; improving quality of life and well-being, cost-effectiveness, independent preparedness and response to local outbreaks, and increased access to funding. Challenges associated with vaccine research and development include the cost of the investment, risk of failure; poor ethical framework and legislation; lack of adequate funding; lack of political will & support; and poor surveillance system. Strategies to create sufficient research funds, an efficient surveillance system, and a legislative framework are clearly described. In conclusion, strengthening vaccine research capacity in Africa requires the political goodwill of African governments and strategic partnerships with international organizations and institutes. The challenges facing this development and possible solutions have been highlighted in this article.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1525

Your browser does not support the canvas element.

PDF Download: 932

Your browser does not support the canvas element.


Full Text View: 744

Your browser does not support the canvas element.